Log In
BCIQ
Print this Print this
 

InRatio2 PT/INR Monitor

  Manage Alerts
Collapse Summary General Information
Company Alere Inc.
DescriptionPoint-of-care anticoagulation monitor
Molecular Target
Mechanism of Action 
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCardiovascular, Diagnostic
Indication DetailsMonitor anticoagulation on warfarin therapy
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$8,400.0M

$5,800.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

02/01/2016

$8,400.0M

$5,800.0M

0

Get a free BioCentury trial today